Yu, H.; Rong, W.; Yang, J.; Lu, J.; Ma, K.; Liu, Z.; Yuan, H.; Xu, L.; Li, Y.; Jing, Z.-C.;
et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Biomarker for Prognostic Assessment and Risk Stratification of Acute Pulmonary Embolism. J. Clin. Med. 2022, 11, 3908.
https://doi.org/10.3390/jcm11133908
AMA Style
Yu H, Rong W, Yang J, Lu J, Ma K, Liu Z, Yuan H, Xu L, Li Y, Jing Z-C,
et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Biomarker for Prognostic Assessment and Risk Stratification of Acute Pulmonary Embolism. Journal of Clinical Medicine. 2022; 11(13):3908.
https://doi.org/10.3390/jcm11133908
Chicago/Turabian Style
Yu, Haixu, Wei Rong, Jie Yang, Jie Lu, Ke Ma, Zhuohui Liu, Hui Yuan, Lei Xu, Yulin Li, Zhi-Cheng Jing,
and et al. 2022. "Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Biomarker for Prognostic Assessment and Risk Stratification of Acute Pulmonary Embolism" Journal of Clinical Medicine 11, no. 13: 3908.
https://doi.org/10.3390/jcm11133908
APA Style
Yu, H., Rong, W., Yang, J., Lu, J., Ma, K., Liu, Z., Yuan, H., Xu, L., Li, Y., Jing, Z.-C., & Du, J.
(2022). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Biomarker for Prognostic Assessment and Risk Stratification of Acute Pulmonary Embolism. Journal of Clinical Medicine, 11(13), 3908.
https://doi.org/10.3390/jcm11133908